Custom Antibody Market Set to Surpass USD 996.05 Million by 2030

The global Custom Antibody Market is poised for robust expansion, projected to grow from USD 501.47 million in 2023 to over USD 996.05 million by 2030, registering a CAGR of 10.3% during the forecast period. This growth is fueled by escalating investments in biopharmaceutical research, the rising demand for personalized medicine, and the increasing prevalence of chronic diseases necessitating targeted therapies.

Ask for Sample to Know US Tariff Impacts on Custom Antibody Market: https://www.maximizemarketresearch.com/request-sample/34046/

Competitive Landscape and Regional Demand

The custom antibody market is characterized by intense competition, with key players including Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories, Inc., Kaneka Eurogentec S.A., and GenScript leading the charge. These companies are continually innovating and expanding their portfolios to meet the growing demand for high-specificity antibodies.

Regionally, North America currently dominates the market, accounting for 41.1% of global revenue in 2023. However, the Asia Pacific region is emerging as the fastest-growing market, expected to reach USD 59.9 million by 2030, driven by increased R&D activities and healthcare investments.

Country-Specific Insights

🇻🇳 Growth Opportunities in Vietnam

Vietnam is witnessing a surge in biopharmaceutical activities, exemplified by Celltrion establishing its overseas corporation in the country in September 2024. This move signifies Vietnam's potential as a hub for custom antibody production and related services.

🇹🇭 Trends in Thailand

Thailand's commitment to advancing its biotech sector is evident through increased government funding and partnerships with global pharmaceutical companies. These initiatives are expected to bolster the custom antibody market in the region.

🇯🇵 Consolidation in Japan

Japan continues to be a leader in antibody research, with companies like Daiichi Sankyo collaborating with global partners to develop innovative therapies. Such collaborations are enhancing Japan's position in the custom antibody market.

🇰🇷 Growth in South Korea

South Korea's Samsung Biologics is expanding its manufacturing capabilities, focusing on monoclonal antibodies and antibody-drug conjugates. The company's partnerships with global pharmaceutical firms underscore South Korea's growing influence in the custom antibody sector.

🇸🇬 Opportunities in Singapore

AstraZeneca announced plans to build a $1.5 billion manufacturing facility in Singapore dedicated to producing antibody-drug conjugates. This investment highlights Singapore's strategic importance in the global custom antibody landscape.

🇺🇸 Trends in the United States

The U.S. custom antibody market generated USD 64.9 million in 2023 and is projected to reach USD 117.2 million by 2030, growing at a CAGR of 8.8%. The country remains a significant player, driven by advanced research infrastructure and substantial healthcare investments.

🇨🇳 Consolidation in China

China's biotech sector is rapidly expanding, with companies like Genmab acquiring ProfoundBio, a US-Chinese drugmaker, for $1.8 billion. This acquisition underscores China's growing prominence in antibody innovation and development.

🇪🇺 Updation in Europe

Europe is experiencing significant developments in the custom antibody market. In December 2022, Merck KGaA collaborated with Kelun-Biotech to develop seven investigational preclinical antibody-drug conjugates for cancer treatment. Additionally, Thermo Fisher Scientific acquired The Binding Site Group, enhancing its specialty diagnostics portfolio.

For Customization of the report, please refer to this link: https://www.maximizemarketresearch.com/inquiry-before-buying/34046/

Key Recent Developments

In November 2023, Abcam plc acquired AbCellerate for £35 million, expanding its custom antibody services.
In October 2023, Bio-Rad Laboratories Inc. launched the Precision Ab platform, utilizing machine learning to optimize custom antibody design.
In September 2023, Kaneka Eurogentec S.A. partnered with Sengenics Corporation to enhance antibody humanization technologies.
Custom Antibody Market Segmentation:

by Service

Antibody Development
Antibody Production & Purification
Antibody Fragmentation & Labeling

Antibody Development, Antibody Production & Purification, and Antibody Fragmentation & Labelling are the three segments of the Custom Antibody Market based on services. In 2023, the segment with the largest market share is Antibody Development. High-quality bespoke antibodies are becoming more and more important to researchers since they can help with reproduction, something that commercial antibodies can't do.

by Type

Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Other

The custom antibody market is divided into four segments based on type: recombinant antibodies, polyclonal antibodies, monoclonal antibodies, and others. As of 2023, the Monoclonal Antibodies segment holds the largest market share. This is because monoclonal antibodies are the best option for all kinds of research studies because they have great specificity and selectivity when compared to other antibodies.

by Source

Mice
Rabbits
Other

The Custom Antibody Market is divided into mice, rabbits, and others based on the source. In 2023, the Rabbits sector holds the largest market share. In 2023, the Mice segment holds the most market share. The most popular hosts for producing antibodies for research purposes are mice. Mice have the advantages of lower feeding costs and easier handling and maintenance because of their small size when compared to other experimental animals.

by Research Area

Oncology
Infectious Disease
Neurobiology
Stem Cells
Immunology
Cardiovascular Disease
Others

Research Area: Oncology, Infectious Disease, Neurobiology, Stem Cells, Immunology, Sports & Energy Drinks, Cardiovascular Disease, and other areas make up the Custom Antibody Market.

by End-User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organization

For deeper market insights, peruse the summary of the research report: https://www.maximizemarketresearch.com/market-report/global-custom-antibody-market/34046/

Custom Antibody Market, Key Players:

1. Thermo Fisher Scientific Inc.
2. Genscript Biotech Corporation
3. Abcam plc
4. Rockland Immunochemicals Inc.
5. Creative Biolabs Inc.
6. RayBiotech Inc.
7. Covance Inc
8. Bio-Rad Laboratories, Inc.
9. Merck Group
10.Cell Signaling Technology, Inc.
11.Agilent Technologies, Inc.
12.BioLegend, Inc.
13.ProMab Biotechnologies
14.Innovagen AB
15.ProteoGenix
16.Abnova Corporation
17.Precision Antibody
18.Sino Biological

Check Out the Latest Trends:

♦ Digital PCR (dPCR) and Realtime PCR (qPCR) Market https://www.maximizemarketresearch.com/market-report/global-digital-pcr-dpcr-and-real-time-pcr-qpcr-market/32992/

♦ Global Rapid Microbiology Testing Market https://www.maximizemarketresearch.com/market-report/global-rapid-microbiology-testing-market/21018/

♦ Global Agricultural Biologicals Market https://www.maximizemarketresearch.com/market-report/global-agricultural-biologicals-market/31007/

♦ Global Viral Vector and Plasmid DNA Manufacturing Market https://www.maximizemarketresearch.com/market-report/global-viral-vector-and-plasmid-dna-manufacturing-market/32167/

♦ Global Bioreactors Market https://www.maximizemarketresearch.com/market-report/global-bioreactors-market/98750/

♦ Global Environmental Monitoring Market https://www.maximizemarketresearch.com/market-report/global-environmental-monitoring-market/31017/

♦ Global Clinical Oncology Next-Generation Sequencing Market https://www.maximizemarketresearch.com/market-report/global-clinical-oncology-next-generation-sequencing-market/100383/

♦ Global Laboratory Proficiency Testing Market https://www.maximizemarketresearch.com/market-report/global-laboratory-proficiency-testing-market/30026/

♦ Floriculture Market https://www.maximizemarketresearch.com/market-report/global-floriculture-market/23982/

♦ Global Membrane Bioreactor (MBR) Systems Market https://www.maximizemarketresearch.com/market-report/global-membrane-bioreactor-systems-market/31266/

♦ Biosimilars Market https://www.maximizemarketresearch.com/market-report/global-biosimilars-market/31668/

♦ Global Commercial Greenhouse Market https://www.maximizemarketresearch.com/market-report/global-commercial-greenhouse-market/110591/

Contact Us:

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Navale IT park Phase 3,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

About Us:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.